Our top pick for
Venator Materials PLC is a specialty chemicals business based in the US. Venator Materials shares (VNTR) are listed on the NYSE and all prices are listed in US Dollars. Venator Materials employs 3,600 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$3.01|
|52-week range||$1.79 - $5.63|
|50-day moving average||$2.95|
|200-day moving average||$3.91|
|Wall St. target price||$4.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.35|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-2.90%|
|1 month (2021-09-23)||5.61%|
|3 months (2021-07-23)||-7.10%|
|6 months (2021-04-23)||-35.82%|
|1 year (2020-10-23)||46.83%|
|2 years (2019-10-23)||15.77%|
|3 years (2018-10-23)||8.6|
|5 years (2016-10-19)||N/A|
Valuing Venator Materials stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Venator Materials's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Venator Materials's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $115 million.
The EBITDA is a measure of a Venator Materials's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2.1 billion|
|Gross profit TTM||$160 million|
|Return on assets TTM||-0.13%|
|Return on equity TTM||-22.05%|
|Market capitalisation||$331.7 million|
TTM: trailing 12 months
There are currently 383,984 Venator Materials shares held short by investors – that's known as Venator Materials's "short interest". This figure is 30.7% down from 554,223 last month.
There are a few different ways that this level of interest in shorting Venator Materials shares can be evaluated.
Venator Materials's "short interest ratio" (SIR) is the quantity of Venator Materials shares currently shorted divided by the average quantity of Venator Materials shares traded daily (recently around 511978.66666667). Venator Materials's SIR currently stands at 0.75. In other words for every 100,000 Venator Materials shares traded daily on the market, roughly 750 shares are currently held short.
However Venator Materials's short interest can also be evaluated against the total number of Venator Materials shares, or, against the total number of tradable Venator Materials shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Venator Materials's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Venator Materials shares in existence, roughly 0 shares are currently held short) or 0.032% of the tradable shares (for every 100,000 tradable Venator Materials shares, roughly 32 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Venator Materials.
Find out more about how you can short Venator Materials stock.
We're not expecting Venator Materials to pay a dividend over the next 12 months.
Over the last 12 months, Venator Materials's shares have ranged in value from as little as $1.79 up to $5.63. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Venator Materials's is 1.8736. This would suggest that Venator Materials's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Venator Materials PLC, together with its subsidiaries, manufactures and markets chemical products worldwide. It operates through two segments, Titanium Dioxide and Performance Additives. The Titanium Dioxide segment offers titanium dioxide (TiO2), such as rutile, anatase, and ultrafine TiO2 products for use in coatings, printing inks, PVC window frames, plastic masterbatches, cosmetics, pharmaceuticals, polyester fibers, polyamide fibers, catalysts, paper, and food and personal care products. The Performance Additives segment provides barium and zinc additives for use in coatings, films, pharmaceuticals, and paper and glass fiber reinforced plastics; and colored inorganic pigments comprising iron oxides, ultramarines, specialty inorganics chemicals, and driers for construction, coatings, plastics, cosmetics, inks, catalyst, and laminates. This segment also offers wood protection chemicals for use in residential and commercial applications; timber treatment chemicals for use in decking, fencing, and other residential outdoor wood structures; industrial construction products for use in telephone poles, and salt water piers and pilings; and water treatment chemicals for the municipal and industrial waste water treatment markets, as well as for the paper industry. Venator Materials PLC was incorporated in 2017 and is headquartered in Stockton-On-Tees, the United Kingdom. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.